SEC Tracker
Get the app

Corcept Therapeutics CORT

William Guyer (Officer) plans to sell 20,000 CORT shares, about $2.3M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Apr 1, 2025
  2. Broker: Stifel Nicolaus & Company Inc.
  3. Shares acquired by: Stock Option Exercise
  4. 10b5-1 plan adopted: Nov 27, 2024

All of William Guyer's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 678 shares at $114.51 on Apr 1, 2025 · Form 4
  • Sold 7,060 shares at $74.31 on May 6, 2025 · Form 4
  • Sold 3,082 shares at $72.75 on Jun 10, 2025 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Corcept Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Repligen RGEN public float $6.0B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  4. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  5. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.